ST Pharm Co.,Ltd., provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical R and D solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.
Metrics to compare | 237690 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship237690PeersSector | |
---|---|---|---|---|
P/E Ratio | 41.6x | 4.8x | −0.5x | |
PEG Ratio | 0.59 | 0.02 | 0.00 | |
Price/Book | 2.9x | 0.9x | 2.6x | |
Price / LTM Sales | 5.3x | 0.6x | 2.9x | |
Upside (Analyst Target) | 61.8% | 55.7% | 53.4% | |
Fair Value Upside | Unlock | 23.8% | 10.2% | Unlock |